Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
Author | Hadi M., Yassine |
Author | Al-Jighefee, Hadeel |
Author | Al-Sadeq, Duaa W. |
Author | Dargham, Soha R. |
Author | Younes, Salma N. |
Author | Shurrab, Farah |
Author | Marei, Reham M. |
Author | Hssain, Ali Ait |
Author | Taleb, Sara |
Author | Alhussain, Hashim A. |
Author | Al-Nesf, Maryiam A. |
Author | Al-Khal, Abdullatif |
Author | Qotba, Hamda |
Author | Althani, Asmaa A. |
Author | Tang, Patrick |
Author | Abu-Raddad, Laith J. |
Author | Nasrallah, Gheyath K. |
Available date | 2020-11-03T04:54:33Z |
Publication Date | 2020-10-27 |
Publication Name | International Journal of Infectious Diseases |
Identifier | http://dx.doi.org/10.1016/j.ijid.2020.10.042 |
Citation | Yassine HM, Al-Jighefee H, Al-Sadeq DW, Dargham SR, Younes SN, Shurrab F, Marei RM, Hssain AA, Taleb S, Alhussain HA, Al-Nesf MA, Al-Khal A, Qotba H, Althani AA, Tang P, Abu-Raddad LJ, Nasrallah GK. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies. Int J Infect Dis. 2020 Oct 27:S1201-9712(20)32246-3. doi: 10.1016/j.ijid.2020.10.042. Epub ahead of print. PMID: 33127504; PMCID: PMC7590641. |
ISSN | 12019712 |
Abstract | ObjectivesTo evaluate and compare the performances of five commercial ELISA assays (EDI, AnshLabs, Dia.Pro, NovaTec, and Lionex) for detecting anti-SARS-CoV-2 IgG. Methods70 negative control samples (collected before the COVID-19 pandemic) and samples from 101 RT-PCR-confirmed SARS-CoV-2 patients (collected at different time points from symptoms onset: ≤7, 8-14, and >14 days) were used to compare the sensitivity, specificity, agreement, positive and negative predictive values of each assay with RT-PCR. A concordance assessment between the five assays was also conducted. Cross-reactivity with other HCoV, non-HCoV respiratory viruses, non-respiratory viruses, and nuclear antigens was investigated. ResultsLionex showed the highest specificity (98.6%, 95%CI: 92.3-99.8), followed by EDI and Dia.Pro (97.1%, 95%CI: 90.2-99.2), NovaTec (85.7%, 95%CI: 75.7-92.1), then AnshLabs (75.7%, 95%CI: 64.5-84.2). All ELISA kits cross-reacted with one anti-MERS IgG positive sample except Lionex. The sensitivity was low during the early stages of the disease but improved over time. After 14 days from symptoms onset, Lionex and NovaTec showed the highest sensitivity at 87.9% (95%CI: 72.7-95.2) and 86.4% (95%CI: 78.5-91.7), respectively. The agreement with RT-PCR results based on Cohen’s kappa was as follows: Lionex (0.89)> NovaTec (0.70)> Dia.Pro (0.69)> AnshLabs (0.63)> EDI (0.55). ConclusionThe Lionex ELISA, which measures antibodies solely to the S1 protein, demonstrated the best performance. |
Sponsor | This work was made possible by grant No. RRC-2-032 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. GKN would like to acknowledge funds from Qatar University's internal grant QUERG-CMED-2020-2. |
Language | en |
Publisher | Elsevier |
Subject | COVID-19 SARS-CoV-2 Serology IgG ELISA Sensitivity Specificity |
Type | Article |
Open Access user License | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
Check access options
Files in this item
This item appears in the following Collection(s)
-
Biomedical Research Center Research [709 items ]
-
Biomedical Sciences [692 items ]
-
COVID-19 Research [799 items ]
-
Medicine Research [1382 items ]